An interventional study of Thyroid Surgery Educational Video in Thyroid Cancer, Thyroid Nodule and TSH, sponsored by West China Hospital. Not yet recruiting. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by West China Hospital · Not applicable, Interventional, and Health services research
The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. This study will explore the feasibility of using guideline-based public education videos on postoperative TSH suppression therapy for differentiated thyroid cancer in the context of public education regarding thyroid surgery.
207 studies on the registry are indexed under Thyroid Nodule; 64 are open to participants now.
This study's planned enrollment of 400 is above the median of 75 across 121 interventional studies indexed under Thyroid Nodule.
Browse Thyroid Nodule studies →West China Hospital is the lead sponsor of 501 studies on the registry; 246 are open to participants now.
Compared within Thyroid Nodule, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Thyroid Neoplasms. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer produced by researchers in accordance with guidelines
Other: Thyroid Surgery Educational Video
Without any additional intervention
Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer created by researchers based on guidelines
TSH Compliance Rate
The criteria for determining the TSH target achievement rate are based on a combination of three factors: the patient's postoperative recurrence risk stratification, the follow-up time point, and the current TSH test result. Within one year postoperatively, the TSH suppression targets are \< 0.1 mU/L for the high-risk group, 0.1-0.5 mU/L for the moderate-risk group, and 0.1-0.5 mU/L (low Tg) or 0.5-2 mU/L (undetectable Tg, lobectomy) for the low-risk group. In statistical analysis, the TSH target range attainment rate = (number of patients with TSH levels within the target range at each follow-up time point / total number of patients followed up at that time point) × 100%
Time frame: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient satisfaction
Patient satisfaction following different educational approaches was assessed using a 5-point Likert scale (1-5 scale; the higher the score, the higher the satisfaction).
Time frame: Immediately after the educational presentation (post-intervention)
Level of knowledge dissemination
Knowledge assessment consists of 6 multiple-choice questions, 2 true/false questions, and 2 fill-in-the-blank questions to evaluate patients' understanding and awareness of educational topic.
Time frame: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient anxiety level
Anxiety scale, thereby assessing the patient's level of anxiety. A 5-point Likert scale was used, with each item scored on a scale of 1 to 5, ranging from "not at all" to "very severe."
Time frame: Baseline (before the educational outreach) and immediately after the educational outreach; two assessments total
Patient's Level of Regret After Surgery
Regret Scale, thereby recording the patient's degree of postoperative regret. 1. This was the right decision. 2\. I regret making this choice. 3. If I had the chance to do it over, I would make the same choice. 4. This choice caused me a lot of pain. 5. This was a wise decision. A 5-point Likert scale was used, with each item scored on a scale of 1 to 5; the lower the score, the less regret the respondent felt.
Time frame: Baseline (before the educational outreach) and immediately after the educational outreach
Incidence of adverse events in patients
Whether the patient has forgotten to take medication or mistakenly recorded the follow-up appointment time, etc.
Time frame: Postoperative Month 1, Postoperative Month 3, and Postoperative Month 6
No study locations are listed for this record.
Start is estimated for Oct 2026; primary completion for Dec 2027, 14 months later.
Of 67 non-industry interventional studies with no phase under Thyroid Nodule, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 46. This study's planned 14 months is below that.
Counting every sponsor, half of 71 studies reached it within 30 months; a quarter within 14 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.